Roche Holding AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RHO6.F | NVS | AZN | GILD | BMY | BIIB | |
|---|---|---|---|---|---|---|
| Market cap | 332.79B | 292.03B | 261.82B | 194.07B | 125.99B | 35.92B |
| P/E (TTM) | 26.1 | 23.2 | 25.2 | — | 13.6 | 43.2 |
| Forward P/E | — | 15.7 | 14.9 | 15.7 | 9.3 | 14.8 |
| Price/book | 9.4 | 7.0 | 5.2 | 16.4 | 5.6 | 1.9 |
| Dividend yield | 2.52% | 3.09% | 1.90% | 2.10% | 4.09% | — |
| 1-year change | +34.73% | +16.90% | +1.43% | +28.86% | +38.48% | +64.57% |
| Today | −0.38% | +2.29% | +2.97% | +2.25% | +4.84% | +4.12% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All RHO6.F news ›Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
Roche will take ex-China development of Hansoh’s two preclinical ADCs and multiple programs against Roche-proposed targets once Hansoh completes global phase 1a trials. The deal includes $400 million upfront and more than $15 billion in…
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Roche Holding AG (RHHVF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK), Roche Holding AG (RHHVF) and Arrowhead Pharmaceuticals (ARWR) with bullish sentiments. In a report released yesterday,…
Roche continues to look to China for new drugs
STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts,…
Hansoh Pharma, Roche Join to Accelerate Global Novel ADC Development
This is the second collaboration between the two companies in the ADC field. Editor’s Take: Leveraging the deep expertise of both Hansoh and Roche will benefit ADC advancement from early development through commercialization. Hansoh Pharma…
Roche investment pause in Germany leaves approved Penzberg project intact
The FINANCIAL — A Roche investment pause in Germany covers future decisions while its approved Penzberg project remains unaffected. The Swiss drugmaker objects to a compulsory medicine-rebate increase taking effect next year. Roche’s…
FDA Approves Roche’s Enspryng for Thyroid Eye Disease | VM
BASEL, Switzerland—Pharmaceutical giant Roche (SIX: RO, ROP; OTCQX: RHHBY) has announced that Enspryng (satralizumab), an at-home subcutaneous treatment for adults with thyroid eye disease (TED), has received U.S. Food and Drug…
Roche’s Enspryng nets a second indication on FDA eye disease approval
While Enspryng is the first drug suitable for at-home administration in TED, analysts are lukewarm on its potential to disrupt the reign of the anti-IGF-1R class. The US Food and Drug Administration (FDA) has granted Roche a label…
The first Christmas at Château de la Roche-Guyon is being prepared in Val-d'Oise, as Winter Tales take center stage.
The Château de La Roche-Guyon is celebrating Noël for the very first time. From 5 December 2026 to 3 January 2027, this landmark of the Val-d'Oise (95) launches its inaugural winter season with Contes d'hiver, a tailor-made experience for…
Thyroid Eye Disease Patients Gain First At-Home Injection Option as FDA Clears Roche's Enspryng for Adults
Adults with thyroid eye disease now have a treatment they can inject at home. Roche announced Oct. 16 that the FDA approved Enspryng (satralizumab) for adults with the condition, making it the first under-the-skin option that a patient or…
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront
By Brian Buntz | October 19, 2026 Roche Towers in Basel, Switzerland. [Adobe Stock] The agreement expands a relationship that began last October, when Roche licensed Hansoh’s CDH17-targeting ADC HS-20110 for $80 million upfront. This time,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com20
-
seekingalpha.com7
-
statnews.com7
-
tradingview.com7
-
freedom959.net6
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.